PURDUE PHARMA LP FDA Approval NDA 205777

NDA 205777

PURDUE PHARMA LP

FDA Drug Application

Application #205777

Documents

Letter2015-07-07
Label2014-07-23
Review2014-08-27
Other2015-11-04
Letter2014-07-23
Letter2014-08-20
Letter2016-04-22
Other2015-06-30
Letter2016-10-03
Label2016-12-20
Letter2016-12-21
Medication Guide2016-12-29
Letter2017-05-31
Label2018-09-21
Label2018-09-21
Medication Guide2018-09-21
Medication Guide2018-09-21
Letter2018-09-28
Letter2018-09-28

Application Sponsors

NDA 205777PURDUE PHARMA LP

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001TABLET, EXTENDED RELEASE;ORAL5MG;10MG1TARGINIQNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
002TABLET, EXTENDED RELEASE;ORAL10MG;20MG1TARGINIQNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
003TABLET, EXTENDED RELEASE;ORAL20MG;40MG1TARGINIQNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP2014-07-23STANDARD
REMS; REMSSUPPL2AP2015-06-26N/A
REMS; REMSSUPPL3AP2016-04-20N/A
LABELING; LabelingSUPPL4AP2016-12-16STANDARD
REMS; REMSSUPPL5AP2016-09-30N/A
REMS; REMSSUPPL7AP2017-05-26N/A
REMS; REMSSUPPL10AP2018-09-18N/A
LABELING; LabelingSUPPL11AP2018-09-18STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null31
SUPPL3Null15
SUPPL4Null6
SUPPL5Null6
SUPPL7Null6
SUPPL10Null7
SUPPL11Null15

CDER Filings

PURDUE PHARMA LP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205777
            [companyName] => PURDUE PHARMA LP
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/205777s010s011lbl.pdf#page=47"]
            [products] => [{"drugName":"TARGINIQ","activeIngredients":"NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","strength":"5MG;10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"TARGINIQ","activeIngredients":"NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","strength":"10MG;20MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"TARGINIQ","activeIngredients":"NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","strength":"20MG;40MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"09\/18\/2018","submission":"SUPPL-11","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205777s010s011lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2018","submission":"SUPPL-10","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205777s010s011lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205777s004lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205777s004lbl.pdf\"}]","notes":""},{"actionDate":"07\/23\/2014","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/205777lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"07\/23\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/205777lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/205777Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2014\\\/205777Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"09\/18\/2018","submission":"SUPPL-11","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205777s010s011lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/205777Orig1s010s011ltr.pdf\"}]","notes":">"},{"actionDate":"09\/18\/2018","submission":"SUPPL-10","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205777s010s011lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/205777Orig1s010s011ltr.pdf\"}]","notes":">"},{"actionDate":"05\/26\/2017","submission":"SUPPL-7","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/205777Orig1s007ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"09\/30\/2016","submission":"SUPPL-5","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205777Orig1s005ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"12\/16\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205777s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205777Orig1s004ltr.pdf\"}]","notes":">"},{"actionDate":"04\/20\/2016","submission":"SUPPL-3","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205777Orig1s003ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"06\/26\/2015","submission":"SUPPL-2","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/205777Orig1s002ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"08\/19\/2014","submission":"SUPPL-1","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/205777Orig1s001ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-09-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.